Related references
Note: Only part of the references are listed.Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation
Yen-Kai Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Therapeutic strategies for Alzheimer's disease in clinical trials
Justyna Godyn et al.
PHARMACOLOGICAL REPORTS (2016)
Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms
Marija Iljina et al.
SCIENTIFIC REPORTS (2016)
Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease
Douglas Walker et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
The Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial Sirtuins
Magdalena Cieslik et al.
PLOS ONE (2015)
A fragment of the receptor for advanced glycation end products restores the spatial memory of animals in a model of Alzheimer's disease
O. M. Volpina et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2015)
Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
Saeed Sadigh-Eteghad et al.
MEDICAL PRINCIPLES AND PRACTICE (2015)
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Priyanka Narayan et al.
BIOCHEMISTRY (2014)
Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes
Guendalina Olivero et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Acetylcholine and antibodies against the acetylcholine receptor protect neurons and astrocytes against beta-amyloid toxicity
Anna V. Kamynina et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Is RAGE still a therapeutic target for Alzheimer's disease?
Richard J. Deane
FUTURE MEDICINAL CHEMISTRY (2012)
Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40 Ratios in Alzheimer Disease
Kris Pauwels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Shi Fang Yan et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Novel pathway for an old neurotransmitter: Dopamine-induced neuronal calcium signalling via receptor-independent mechanisms
Annika Vaarmann et al.
CELL CALCIUM (2010)
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
Ravichandran Ramasamy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism
LF Lue et al.
EXPERIMENTAL NEUROLOGY (2001)
Share Paper
